Tag Archives: GLPG

Galapagos NV (GLPG)

Galapagos NV is a Belgium-based biotechnology company. The Company’s activities are divided into two operating divisions: Research and Development (R & D) and Services. The R & D division is engaged in the discovery and development of small molecules. The Services division, offers target-to-drug discovery products and services to pharmaceutical and biotechnology companies and to....More>>>

News about GLPG

Gilead Doubles Down On CAR-T: Updates To Thesis
From:seekingalpha.com
Shares of Gilead Sciences (GILD) have risen by over 10% since my initial article in April which called the stock a core buy in biotech with several value drivers. GILD data by YCharts Long time readers know that I´m a fan of value catalyst plays, ...Read More>>>

Galapagos: Buy The Dip
From:seekingalpha.com
Shares of Belgian biotech Galapagos (GLPG) have dipped considerably in the past couple months along with general weakness in the biotech sector, potentially offering would-be investors an entry point into the stock. Even after recent price action the...Read More>>>

Orbimed Advisors Llc Buys Clementia Pharmaceuticals Inc, Aetna Inc, Universal Health Services Inc, S
From:www.gurufocus.com
New York, NY, based Investment company Orbimed Advisors Llc buys Clementia Pharmaceuticals Inc, Aetna Inc, Universal Health Services Inc, Immunomedics Inc, Kala Pharmaceuticals Inc, Alnylam Pharmaceuticals Inc, Juno Therapeutics Inc, Regeneron Pharma...Read More>>>

Money Morning Top Outperformers
From:moneymorning.com
Our financial experts – with a combined 250+ years in the markets – continue to give us solid investing guidance every week. And the recommendations they pair with their industry and market analysis are doing very well – as...Read More>>>

Gilead: Oncology Acquisition Incoming
From:seekingalpha.com
Executive Summary Gilead (NASDAQ:GILD) has a pipeline that won't see real read-outs for years. Thus, investors are antsy and pushing for M&A. Gilead seems most content with its NASH and HBV internal efforts, but may be interested in inflammati...Read More>>>